These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24240044)

  • 41. An algorithm for model construction and its applications to pharmacogenomic studies.
    Liang KH; Hwang Y; Shao WC; Chen EY
    J Hum Genet; 2006; 51(9):751-759. PubMed ID: 16900297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Note of clarification regarding data on the association between the interleukin-1β -511C>T polymorphism and breast cancer risk.
    Wang Y; Chu X; Wang H
    Breast Cancer Res Treat; 2016 Feb; 155(3):419-21. PubMed ID: 26892464
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatitis: A variant resulting in hypofunctional IRAK2 hampers spontaneous clearance of HCV.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):552. PubMed ID: 26303673
    [No Abstract]   [Full Text] [Related]  

  • 44. Interleukin-28 Polymorphism: Ethnic variations and the response to chronic hepatitis C treatment in Malaysia.
    Hoe CH; Suan MAM; Hoe CH; Tang TH; Kiew KK; Hassan MRA; Chan HK
    Med J Malaysia; 2018 Aug; 73(4):260. PubMed ID: 30121693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene-Gene Interaction Study Between Genetic Polymorphisms of Folate Metabolism and MTR SNPs on Prognostic Features Impact for Breast Cancer.
    Omran MH; Fotouh BE; Shosha WG; Ismail A; Ramadan SS
    Rep Biochem Mol Biol; 2022 Apr; 11(1):89-101. PubMed ID: 35765535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females.
    Omran MH; Fotouh BE; Shousha WG; Ismail A; Ibrahim NE; Ramadan SS
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):617-626. PubMed ID: 33639682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review.
    Dadmanesh M; Ranjbar MM; Ghorban K
    Immunol Lett; 2019 Apr; 208():11-18. PubMed ID: 30831142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.
    El-Emshaty HM; Nasif WA; Mohamed IE
    Dis Markers; 2015; 2015():707254. PubMed ID: 26783377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.
    Yee BE; Nguyen NH; Zhang B; Lin D; Vutien P; Wong CR; Lutchman GA; Nguyen MH
    BMJ Open Gastroenterol; 2015; 2(1):e000049. PubMed ID: 26462288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
    Yee BE; Nguyen NH; Zhang B; Vutien P; Wong CR; Lutchman GA; Nguyen MH
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1189-201. PubMed ID: 25171028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Innate Immunity in Hepatitis C Virus Infection.
    Schwerk J; Negash A; Savan R; Gale M
    Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 32341066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C viral dynamics: basic concept and clinical significance.
    Jessner W; Watkins-Riedel T; Formann E; Steindl-Munda P; Ferenci P
    J Clin Virol; 2002 Dec; 25 Suppl 3():S31-9. PubMed ID: 12467775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of interleukin-1β gene to treatment response in chronic patients infected with HCV genotype 4.
    Omran MH; Ibrahim NE; Youssef SS; Fatouh BE; Nabil W; El-Shami MM; El Awady MK
    J Infect Dev Ctries; 2013 Nov; 7(11):851-8. PubMed ID: 24240044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphism of low-density lipoprotein receptor did not affect treatment outcome of chronic hepatitis C genotype 3.
    Tanwandee T; Pithukpakorn M; Vipatakul N; Charatcharoenwitthaya P; Chainuvati S; Nimanong S; Prachayakul V; Pongprasobchai S; Manatsathit S; Leelakusolvong S; Pausawasdi N; Kachintorn U; Limwongse C; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S147-53. PubMed ID: 21721440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.